-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fix5WKy2A3kSWj4zdVmNtJYvg75jh2cTQAXY8kTSlWynRim7cEArT0eFmn2j8U6d LfEGAoF8LACtg9PAFAYmwQ== 0001209191-03-021668.txt : 20030915 0001209191-03-021668.hdr.sgml : 20030915 20030915191321 ACCESSION NUMBER: 0001209191-03-021668 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030911 FILED AS OF DATE: 20030915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVY RALPH E CENTRAL INDEX KEY: 0001221592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22890 FILM NUMBER: 03896551 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGSTAT MEDICAL CORP CENTRAL INDEX KEY: 0000913610 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943076069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5107894300 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc4.xml FORM 4 SUBMISSION X0201 42003-09-111 0000913610 SANGSTAT MEDICAL CORP SANG 0001221592 LEVY RALPH E 6300 DUMBARTON CIRCLE FREMONT CA 94555 0100SVP OperationsCommon Stock2003-09-114M0625010.75A6250DCommon Stock2003-09-114D0625022.5D0DCommon Stock2003-09-114M0802210.2031A8022DCommon Stock2003-09-114D0802222.5D0DCommon Stock2003-09-114M01697810.2031A16978DCommon Stock2003-09-114D01697822.5D0DCommon Stock2003-09-114M0301912.99A3019DCommon Stock2003-09-114D0301922.5D0DCommon Stock2003-09-114M01048112.99A10481DCommon Stock2003-09-114D01048122.5D0DCommon Stock2003-09-114M0229919.38A2299DCommon Stock2003-09-114D0229922.5D0DCommon Stock2003-09-114M02570119.38A25701 DCommon Stock2003-09-114D02570122.5D0DCommon Stock2003-09-114M0102108.07A10210DCommon Stock2003-09-114D01021022.5D0DCommon Stock2003-09-114M0247908.07A24790DCommon Stock2003-09-114D02479022.5D0DOption vesting was accelerated and the resulting common stock from the exercise and all outstanding common stock was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.Ralph E. Levy Form 4 [2 of 2] See attached footnote page.Tamiko F. Lewis, Attorney-in-Fact for Ralph E. Levy2003-09-15 -----END PRIVACY-ENHANCED MESSAGE-----